D 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal Neurons
The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Abstract
The striatum, which is the major component of the basal ganglia in the brain, is regulated in part by dopaminergic input from the substantia nigra. Severe movement disorders result from the loss of striatal dopamine in patients with Parkinson's disease. Rats with lesions of the nigrostriatal dopamine pathway caused by 6-hydroxydopamine (6-OHDA) serve as a model for Parkinson's disease and show alterations in gene expression in the two major output systems of the striatum to the globus pallidus and substantia nigra. Striatopallidal neurons show a 6-OHDA-induced elevation in their specific expression of messenger RNAs (mRNAs) encoding the D 2 dopamine receptor and enkephalin, which is reversed by subsequent continuous treatment with the D 2 agonist quinpirole. Conversely, striatonigral neurons show a 6-OHDA-induced reduction in their specific expression of mRNAs encoding the D 1 dopamine receptor and substance P, which is reversed by subsequent daily injections of the D 1 agonist SKF-38393. This treatment also increases dynorphin mRNA in striatonigral neurons. Thus, the differential effects of dopamine on striatonigral and striatopallidal neurons are mediated by their specific expression of D 1 and D 2 dopamine receptor subtypes, respectively.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The NAc is composed of a vast array of transcriptionally distinct neuronal subtypes, where medium spiny neurons (MSNs) make up the majority (>95%) of the cells (16).”
From Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression (2017) · cites this paper as [16]
In the citing paper
“These neurons are defined by their transcriptional profiles, including dopamine receptor 1 (D1) vs. dopamine receptor 2 (D2) expression, substance P and enkephalin, and other enriched genes (16–18).”
From Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression (2017) · cites this paper as [16]
Citations
Cites
The functional anatomy of basal ganglia disorders
Albin, R. L., Young, A. B., & Penney, J. B. (1989) · Trends in Neurosciences · doi:10.1016/0166-2236(89)90074-x · Cited by 5,353
Multiple receptors for dopamine
Kebabian, J. W., & Calne, D. B. (1979) · Nature · doi:10.1038/277093a0 · Cited by 3,725
DOPAMINE (3-HYDROXYTYRAMINE) AND BRAIN FUNCTION
HORNYKIEWICZ, O. (1966) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07154-6 · Cited by 1,442
Fluoro-gold: a new fluorescent retrograde axonal tracer with numerous unique properties
Schmued, L. C., & Fallon, J. H. (1986) · Brain Research · doi:10.1016/0006-8993(86)91199-6 · Cited by 886
Freund, T. F., Powell, J. F., & Smith, A. D. (1984) · Neuroscience · doi:10.1016/0306-4522(84)90294-x · Cited by 865
Hikosaka, O., & Wurtz, R. H. (1983) · Journal of Neurophysiology · doi:10.1152/jn.1983.49.5.1285 · Cited by 808
Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain.
Young, W. S., Bonner, T. I., & Brann, M. R. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.24.9827 · Cited by 743
Gerfen, C. R., & Scott Young, W. (1988) · Brain Research · doi:10.1016/0006-8993(88)91217-6 · Cited by 658
Self-citationMultiple D2 dopamine receptors produced by alternative RNA splicing
Monsma, F. J., McVittie, L. D., Gerfen, C. R., Mahan, L. C., & Sibley, D. R. (1989) · Nature · doi:10.1038/342926a0 · Cited by 641
Self-citationProjection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin
Kawaguchi, Y., Wilson, C., & Emson, P. (1990) · The Journal of Neuroscience · doi:10.1523/jneurosci.10-10-03421.1990 · Cited by 565
Research works printed but not linked: 1
- HONG, J.S., ADVANCES IN BIOCHEMICAL PSYCHOPHARMACOLOGY 24: 223 (1980).
Cited by
Items 301–400 of 1,013
The control of seizures by the basal ganglia? A review of experimental data
Deransart, C., & Depaulis, A. (2002) · Epileptic Disorders · doi:10.1684/j.1950-6945.2002.tb00547.x · Cited by 151
Ince, E., Ciliax, B. J., & Levey, A. I. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199712)27:4<357::aid-syn9>3.0.co;2-b · Cited by 175
Cell-specific pallidal intervention induces long-lasting motor recovery in dopamine-depleted mice
Mastro, K. J., Zitelli, K. T., Willard, A. M., Leblanc, K. H., Kravitz, A. V., & Gittis, A. H. (2017) · Nature Neuroscience · doi:10.1038/nn.4559 · Cited by 175
Regulation of phosphorylation of the GluR1 AMPA receptor by dopamine D2 receptors
Håkansson, K., Galdi, S., Hendrick, J., Snyder, G., Greengard, P., & Fisone, G. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03558.x · Cited by 156
Dopamine imbalance in Huntington's disease: a mechanism for the lack of behavioral flexibility
Chen, J. Y., Wang, E. A., Cepeda, C., & Levine, M. S. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00114 · Cited by 174
Howes, S. R., Dalley, J. W., Morrison, C. H., Robbins, T. W., & Everitt, B. J. (2000) · Psychopharmacology · doi:10.1007/s002130000451 · Cited by 174
Gruber, A. J., & McDonald, R. J. (2012) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2012.00050 · Cited by 173
What is the degree of segregation between striatonigral and striatopallidal projections?
Bertran-Gonzalez, J. (2010) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2010.00136 · Cited by 173
Hervé, D., Le Moine, C., Corvol, J.-C., Belluscio, L., Ledent, C., Fienberg, A. A., Jaber, M., Studler, J.-M., & Girault, J.-A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-12-04390.2001 · Cited by 173
Lidow, M. S., & Goldman-Rakic, P. S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4353 · Cited by 173
Han, I., You, Y., Kordower, J. H., Brady, S. T., & Morfini, G. A. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06672.x · Cited by 172
Distribution of adenosine A2 receptor mRNA in the human brain
Schiffmann, S. N., Libert, F., Vassart, G., & Vanderhaeghen, J.-J. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90391-6 · Cited by 172
Robertson, G. S., & Jian, M. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00426-6 · Cited by 172
Martín, A. B. B., Fernández‐Espejo, E., Ferrer, B., Gorriti, M. Á., Bilbao, A., Navarro, M. A., de Fonseca, F. R., & Moratalla, R. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301558 · Cited by 172
Keeler, J. F., Pretsell, D. O., & Robbins, T. W. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.07.021 · Cited by 172
Dopaminergic denervation and spine loss in the striatum of MPTP-treated monkeys
Villalba, R. M., Lee, H., & Smith, Y. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2008.09.025 · Cited by 171
Dopamine-dependent synaptic plasticity in striatum during in vivo development
Tang, K.-C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.031374698 · Cited by 171
Feyder, M., Bonito-Oliva, A., & Fisone, G. (2011) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00071 · Cited by 171
Aubert, I., Ghorayeb, I., Normand, E., & Bloch, B. (2000) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(20000228)418:1<22::aid-cne2>3.0.co;2-q · Cited by 170
Paillé, V., Picconi, B., Bagetta, V., Ghiglieri, V., Sgobio, C., Di Filippo, M., Viscomi, M. T., Giampà, C., Fusco, F. R., Gardoni, F., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.2149-10.2010 · Cited by 170
Svenningsson, P., Nomikos, G. G., Ongini, E., & Fredholm, B. B. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00046-8 · Cited by 170
Sgambato-Faure, V., & Cenci, M. A. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.10.005 · Cited by 169
Volman, S. F., Lammel, S., Margolis, E. B., Kim, Y., Richard, J. M., Roitman, M. F., & Lobo, M. K. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.3250-13.2013 · Cited by 168
Sensorimotor assessment of the unilateral 6-hydroxydopamine mouse model of Parkinson's disease
Glajch, K. E., Fleming, S. M., Surmeier, D. J., & Osten, P. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.12.007 · Cited by 168
Valjent, E., Pagès, C., Rogard, M., Besson, M., Maldonado, R., & Caboche, J. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01652.x · Cited by 168
The selective vulnerability of striatopallidal neurons
Mitchell, I. J., Cooper, A. J., & Griffiths, M. R. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00019-2 · Cited by 168
Mean-field modeling of the basal ganglia-thalamocortical system. I
van Albada, S. J., & Robinson, P. A. (2009) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2008.12.018 · Cited by 168
Ridray, S., Griffon, N., Mignon, V., Souil, E., Carboni, S., Diaz, J., Schwartz, J., & Sokoloff, P. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00173.x · Cited by 156
Schwarzschild, M. A., Cole, R. L., & Hyman, S. E. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-10-03455.1997 · Cited by 157
Anderson, K. D., & Reiner, A. J. (1991) · Brain Research · doi:10.1016/0006-8993(91)91403-n · Cited by 168
Role of the Endogenous Cannabinoid System in the Regulation of Motor Activity
Rodrı́guez de Fonseca, F., Del Arco, I., Martı́n-Calderón, J. L., Gorriti, M. A., & Navarro, M. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0217 · Cited by 167
DARPP-32 mediates the actions of multiple drugs of abuse
Svenningsson, P., Nairn, A. C., & Greengard, P. (2005) · The AAPS Journal · doi:10.1208/aapsj070235 · Cited by 167
Differential Tonic GABA Conductances in Striatal Medium Spiny Neurons
Ade, K. K., Janssen, M. J., Ortinski, P. I., & Vicini, S. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3908-07.2008 · Cited by 167
Dopamine receptor supersensitivity
Kostrzewa, R. M. (1995) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(94)00019-w · Cited by 167
The Significance of Continuous Dopaminergic Stimulation in the Treatment of Parkinson??s Disease
Chase, T. N. (1998) · Drugs · doi:10.2165/00003495-199855001-00001 · Cited by 167
Self-citationDeep brain stimulation foundations and future trends
Tierney, T. S. (2017) · Frontiers in bioscience · doi:10.2741/4586 · Cited by 167
Neuroprotective role of adenosine in the CNS.
Wardas, J. (2002) · PubMed · Cited by 167
Hart, G., Leung, B. K., & Balleine, B. W. (2014) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.11.003 · Cited by 166
Mannella, F., Gurney, K., & Baldassarre, G. (2013) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2013.00135 · Cited by 166
“Two distinct sub-populations of neurons can be distinguished in the striatum, one expressing low-affinity D1-like receptors and the other expressing high-affinity D2-like receptors (Gerfen et al., 1990; Floresco et al., 2003; Goto and Grace, 2005).”
Gonzales, K. K., & Smith, Y. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12762 · Cited by 166
Synaptic Integration Mediated by Striatal Cholinergic Interneurons in Basal Ganglia Function
Kaneko, S., Hikida, T., Watanabe, D., Ichinose, H., Nagatsu, T., Kreitman, R. J., Pastan, I., & Nakanishi, S. (2000) · Science · doi:10.1126/science.289.5479.633 · Cited by 166
Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease
Richardson, P. J., Kase, H., & Jenner, P. G. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)90660-x · Cited by 166
Dopamine receptor interactions: some implications for the treatment of Parkinson's disease
Robertson, H. A. (1992) · Trends in Neurosciences · doi:10.1016/0166-2236(92)90034-6 · Cited by 166
Quantitative immunocytochemistry of DARPP-32-expressing neurons in the rat caudatoputamen
Ouimet, C. C., Langley-Gullion, K. C., & Greengard, P. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00724-0 · Cited by 165
Greengard, P., Nairn, A. C., Girault, J., Ouimet, C. C., Snyder, G. L., Fisone, G., Allen, P. B., Fienberg, A. A., & Nishi, A. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00057-x · Cited by 165
Bouabid, S., Tinakoua, A., Lakhdar‐Ghazal, N., & Benazzouz, A. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13442 · Cited by 164
An open-source device for measuring food intake and operant behavior in rodent home-cages
Matikainen‐Ankney, B. A., Earnest, T., Ali, M. A. S., Casey, E., Wang, J. G., Sutton, A. K., Legaria, A. A., Barclay, K. M., Murdaugh, L. B., Norris, M. R., et al. (2021) · eLife · doi:10.7554/elife.66173 · Cited by 164
Cocaine exposure reorganizes cell type– and input-specific connectivity in the nucleus accumbens
MacAskill, A. F., Cassel, J. M., & Carter, A. G. (2014) · Nature Neuroscience · doi:10.1038/nn.3783 · Cited by 163
Alcantara, A. A., Chen, V., Herring, B. E., Mendenhall, J. M., & Berlanga, M. L. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03165-2 · Cited by 163
Rouse, S. T., Marino, M. J., Bradley, S. R., Awad, H., Wittmann, M., & Conn, P. J. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00098-x · Cited by 162
Therapeutic approaches to Huntington disease: from the bench to the clinic
Caron, N. S., Dorsey, E. R., & Hayden, M. R. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.133 · Cited by 162
Circuit specificity in the inhibitory architecture of the VTA regulates cocaine-induced behavior
Edwards, N. J., Tejeda, H. A., Pignatelli, M., Zhang, S., McDevitt, R. A., Wu, J., Bass, C. E., Bettler, B., Morales, M., & Bonci, A. (2017) · Nature Neuroscience · doi:10.1038/nn.4482 · Cited by 162
Chang, P.-C., Pollema-Mays, S. L., Centeno, M. V., Procissi, D., Contini, M., Baria, A. T., Martina, M., & Apkarian, A. V. (2014) · Pain · doi:10.1016/j.pain.2014.02.019 · Cited by 161
“It was surprising to see a tight correlation between DR1a and DR2 expression, given that they comprise 2 parallel NAc transmission pathways: DR1a expression defines the striatonigral neurons in the direct pathway containing dynorphin, the endogenous ligand for KOR; whereas DR2 are expressed on neurons that comprise th…”
BackgroundReward-Modulated Motor Information in Identified Striatum Neurons
Isomura, Y., Takekawa, T., Harukuni, R., Handa, T., Aizawa, H., Takada, M., & Fukai, T. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0381-13.2013 · Cited by 161
Dopaminergic Modulation of Axon Collaterals Interconnecting Spiny Neurons of the Rat Striatum
Guzmán, J. N., Hernández, A., Galarraga, E., Tapia, D., Laville, A., Vergara, R., Aceves, J., & Bargas, J. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-26-08931.2003 · Cited by 161
Tremulous jaw movements in rats:a model of parkinsonian tremor
Salamone, J. D., Mayorga, A. J., Trevitt, J. T., Cousins, M. S., Conlan, A., & Nawab, A. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00053-7 · Cited by 161
Midbrain dopamine system electrophysiological functioning: A review and new hypothesis
Bunney, B. S., Chiodo, L. A., & Grace, A. A. (1991) · Synapse · doi:10.1002/syn.890090202 · Cited by 161
Deng, Y., Lei, W., & Reiner, A. J. (2006) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2006.07.001 · Cited by 161
Fenu, S., Pinna, A., Ongini, E., & Morelli, M. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00944-2 · Cited by 161
Cell-type-specific asynchronous modulation of PKA by dopamine in learning
Lee, S. J., Lodder, B., Chen, Y., Patriarchi, T., Tian, L., & Sabatini, B. L. (2021) · Nature · doi:10.1038/s41586-020-03050-5 · Cited by 160
Sidibé, M., & Smith, Y. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00367-4 · Cited by 160
Adenosine A2A receptors, dopamine D2 receptors and their interactions in Parkinson's disease
Fuxe, K., Marcellino, D., Genedani, S., & Agnati, L. (2007) · Movement Disorders · doi:10.1002/mds.21440 · Cited by 160
Wearing‐off fluctuations in Parkinson's disease: Contribution of postsynaptic mechanisms
Bravi, D., Mouradian, M. M., Roberts, J. W., Davis, T. L., Sohn, Y. H., & Chase, T. N. (1994) · Annals of Neurology · doi:10.1002/ana.410360108 · Cited by 160
Self-citationDirect and indirect dorsolateral striatum pathways reinforce different action strategies
Vicente, A. M., Galvão-Ferreira, P., Tecuapetla, F., & Costa, R. M. (2016) · Current Biology · doi:10.1016/j.cub.2016.02.036 · Cited by 137
Fulton, S. (2010) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.10.003 · Cited by 159
Wolterink, G., Phillips, G., Cador, M., Donselaar-Wolterink, I., Robbins, T. W., & Everitt, B. J. (1993) · Psychopharmacology · doi:10.1007/bf02251293 · Cited by 158
Basal Ganglia Mechanisms of Reward‐Oriented Eye Movement
HIKOSAKA, O. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1390.012 · Cited by 158
Henry, B., Crossman, A. R., & Brotchie, J. M. (1999) · Experimental Neurology · doi:10.1006/exnr.1998.6996 · Cited by 158
Bentivoglio, M., & Morelli, M. (2005) · Handbook of chemical neuroanatomy · doi:10.1016/s0924-8196(05)80005-3 · Cited by 157
Ferrer, B., Asbrock, N., Kathuria, S., Piomelli, D., & Giuffrida, A. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02896.x · Cited by 156
Dopamine D2 receptor mediated presynaptic inhibition of striatopallidal GABAA IPSCs in vitro
Cooper, A. J., & Stanford, I. M. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00038-7 · Cited by 156
Mechanisms of neuromodulatory volume transmission
Özçete, Ö. D., Banerjee, A., & Kaeser, P. S. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02608-3 · Cited by 155
Aberrant Striatal Activity in Parkinsonism and Levodopa-Induced Dyskinesia
Ryan, M. B., Bair-Marshall, C., & Nelson, A. B. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.059 · Cited by 154
Chartoff, E. H., & Connery, H. S. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00116 · Cited by 154
A Subpopulation of Striatal Neurons Mediates Levodopa-Induced Dyskinesia
Girasole, A. E., Lum, M. Y., Nathaniel, D., Bair-Marshall, C. J., Guenthner, C. J., Luo, L., Kreitzer, A. C., & Nelson, A. (2018) · Neuron · doi:10.1016/j.neuron.2018.01.017 · Cited by 154
Cell-Type-Specific Afferent Innervation of the Nucleus Accumbens Core and Shell
Li, Z., Chen, Z., Fan, G., Li, A., Yuan, J., & Xu, T. (2018) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2018.00084 · Cited by 153
Trajectory of adolescent cannabis use on addiction vulnerability
Hurd, Y. L., Michaelides, M., Miller, M. L., & Jutras-Aswad, D. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.07.028 · Cited by 153
Effects of Dopamine D1-like and D2-likeAgonists in Rats that Self-Administer Cocaine
Caine, S. B., Negus, S. S., Mello, N. K., & Bergman, J. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35108-0 · Cited by 153
Popoli, P., Pèzzola, A., Torvinen, M., Reggio, R., Pintor, A., Scarchilli, L., Fuxé, K., & Ferré, S. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00256-1 · Cited by 153
Ageing and the nigrostriatal dopaminergic system
Reeves, S., Bench, C., & Howard, R. (2002) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.606 · Cited by 135
Henry, B., Duty, S., Fox, S. H., Crossman, A. R., & Brotchie, J. M. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00064-5 · Cited by 153
Dopamine in the striatum modulates seizures in a genetic model of absence epilepsy in the rat
Deransart, C., Riban, V., Lê, B.-T., Marescaux, C., & Depaulis, A. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00266-9 · Cited by 152
The Neuroanatomical Organization of the Basal Ganglia
Gerfen, C. R., & Bolam, J. P. (2010) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-374767-9.00001-9 · Cited by 152
Self-citationJohansson, B. A., Lindström, K., & Fredholm, B. B. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90288-7 · Cited by 152
Drago, J., Gerfen, C. R., Westphal, H., & Steiner, H. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00145-5 · Cited by 152
Self-citationKonradi, C., Kobierski, L. A., Nguyen, T. V., Heckers, S., & Hyman, S. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.15.7005 · Cited by 144
Richard, J. M., & Berridge, K. C. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.1339-11.2011 · Cited by 151
Blanchet, P. J., Calon, F., Martel, J. C., Bédard, P. J., Di Paolo, T., Walters, R. R., & Piercey, M. F. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24503-7 · Cited by 142
Cell Type-Specific Alterations in the Nucleus Accumbens by Repeated Exposures to Cocaine
Kim, J., Park, B.-H., Lee, J. H., Park, S. K., & Kim, J. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.01.013 · Cited by 151
Serotonergic sprouting is induced by dopamine-lesion in substantia nigra of adult rat brain
Zhou, F., Bledsoe, S. B., & Murphy, J. M. (1991) · Brain Research · doi:10.1016/0006-8993(91)90553-8 · Cited by 151
A2a adenosine receptor gene expression in developing rat brain
Weaver, D. R. (1993) · Molecular Brain Research · doi:10.1016/0169-328x(93)90058-w · Cited by 151
Chen, J. F., Aloyo, V. J., & Weiss, B. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90238-b · Cited by 151
Muscarinic modulation of striatal function and circuitry
Goldberg, J. A., Ding, J. B., & Surmeier, D. J. (2012) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-23274-9_10 · Cited by 150
Learning from Action: Reconsidering Movement Signaling in Midbrain Dopamine Neuron Activity
Coddington, L. T., & Dudman, J. T. (2019) · Neuron · doi:10.1016/j.neuron.2019.08.036 · Cited by 150
Akineto-rigid vs. tremor syndromes in Parkinsonism
Zaidel, A., Arkadir, D., Israel, Z., & Bergman, H. (2009) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32832d9d67 · Cited by 150
Spectrally Resolved Fiber Photometry for Multi-component Analysis of Brain Circuits
Meng, C., Zhou, J., Papaneri, A., Peddada, T., Xu, K., & Cui, G. (2018) · Neuron · doi:10.1016/j.neuron.2018.04.012 · Cited by 150
A Gαs DREADD Mouse for Selective Modulation of cAMP Production in Striatopallidal Neurons
Farrell, M. S., Pei, Y., Wan, Y., Yadav, P. N., Daigle, T. L., Urban, D. J., Lee, H.-M., Sciaky, N., Simmons, A., Nonneman, R. J., et al. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.251 · Cited by 150
Marchand, W. R. (2010) · Brain Structure and Function · doi:10.1007/s00429-010-0280-y · Cited by 150
Eng, G. K., Sim, K., & Chen, S.-H. A. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.03.002 · Cited by 148
Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse
Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010967 · Cited by 148
Metadata
- Authors
- Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., Monsma, F. J., & Sibley, D. R.
- Affiliations
- National Institutes of Health (US)
- Venue
- Science
- Published
- 1990-12-07
- Volume
- 250
- Issue
- 4986
- Pages
- 1429-1432
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1991603311
- Cited by
- 2,967
- References
- 38
- Citations by year
- 2026: 54 · 2025: 60 · 2024: 73 · 2023: 64 · 2022: 89 · 2021: 84 · 2020: 79 · 2019: 85 · 2018: 90 · 2017: 79 · 2016: 102 · 2015: 106 · 2014: 95 · 2013: 79 · 2012: 97
- FWCI
- 27.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Keywords
- dopamine D1 receptor, dopamine D2 receptor, striatonigral neurons, striatopallidal neurons, gene expression, 6-hydroxydopamine lesion, Parkinson's disease model, substantia nigra, globus pallidus, enkephalin, substance P, dynorphin, quinpirole, SKF 38393, basal ganglia, dopamine agonists
- MeSH terms
- Animals, Cerebral Cortex, Corpus Striatum, Ergolines, Gene Expression Regulation, Globus Pallidus, Hydroxydopamines, Models, Neurological, Neurons, Receptors, Dopamine, RNA, Messenger, Substantia Nigra, Thalamus, Oligonucleotide Probes, 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine, Oxidopamine, Receptors, Dopamine D1, Receptors, Dopamine D2, Quinpirole, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.